Periodic Reporting for period 1 - GCG-T3 Dyslipidemia (Validation and Molecular Characterization of Novel Glucagon-Thyroid Hormone Conjugates for the Efficient Management of Dyslipidemia and Fatty Liver Disease)

Cardiovascular disease (CDV) is one of the main causes of death worldwide. Elevated levels of blood lipids (dyslipidemia) is a well-documented risk factor for CVD. Particularly, elevated low-density lipoprotein cholesterol (LDL-C) levels are known to play a critical role in...